Navigation Links
Delcath to Present at the 2010 Wedbush Securities Life Sciences Best Ideas Management Access Conference
Date:7/28/2010

liver cancers.  Delcath recently concluded a Phase III metastatic melanoma study, and the Company is currently conducting a multi-arm Phase II trial to treat other liver cancers. The Company has not yet received FDA or any foreign regulatory approval for commercial sale of its system.  For more information, please visit the Company's website at www.delcath.com.  

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the acceptability of the Phase III clinical trial data by the FDA, our ability to successfully complete an FDA new drug application, acceptance of the new drug application by the FDA, approval by the FDA or other regulatory authorities of the current or future drug delivery system for the treatment of metastatic melanoma, our ability to successfully complete other clinical trials and secure regulatory approval of our current or future drug-delivery system for the treatment of other liver cancers and other organs, the potential of chemosaturation therapy via PHP as a treatment for patients with terminal metastatic disease in the liver, actions by the FDA or other regulatory agencies  and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Systems Announces Second Quarter Progress Report Conference Call
2. Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago
3. Delcaths Eamonn Hobbs to Ring NASDAQ Opening Bell
4. Delcath Systems Provides Update on Corporate Developments
5. Delcath Signs First Partner Agreement in Asia
6. Delcath Systems Begins Data Analysis of Phase III Trial
7. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
8. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
9. Delcath Systems Reports Substantial Progress
10. Delcath Systems Announces Completion of Public Offering
11. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Va. , Aug. 21, 2014 ... quality and Manufacturing Intelligence , today announces ... Conference. The event will be held Oct. 9-10, ... and is designed to showcase the necessity for ... of metrics and Manufacturing Intelligence to gain insight ...
(Date:8/21/2014)... Aug. 21, 2014  The board of directors of ... provider of clinical trial imaging solutions, today announced that ... financial officer, effective immediately.  Mr. Groff has held the ... He joined VirtualScopics in January 2006 as an accounting ... "When the board of VirtualScopics asked Jim ...
(Date:8/21/2014)... 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ) ... Quarterly highlights 1   Operating ... the first quarter of fiscal 2014, and other achievements, include: ... increase of 6.8%; , Strong international net sales of ... basis; , U.S. net product sales reached a new ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16
... , STAMFORD, Conn., Nov. 13 ... will be releasing a free trial version of its Zargis ... conference, taking place this November 15-17 in Orlando. Zargis is ... the companion hardware -- the 3M Littmann Electronic Stethoscope Model ...
... BERWYN, Pa., Nov. 13 /PRNewswire-FirstCall/ -- Encorium Group, ... multinational clinical research organization (CRO) conducting studies in over ... and biotechnology companies, today announced that it has appointed ... 7, 2009. Ms. Laitinen, age 43, will replace ...
Cached Medicine Technology:Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 3Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors 2Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors 3
(Date:8/21/2014)... is to focus on her body in terms of ... her as a complete human being with thoughts and ... in the media, how does it affect individual romantic ... Quarterly , a SAGE journal, finds that more objectification ... incidents of sexual pressure and coercion., Researchers Laura R. ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The results ... today in The Journal of the American Medical Association ... invasive cancers and reduces unnecessary recalls. Memorial Healthcare System ... the study. , “This study confirms what we already ... harmful cancers we want to find and, at the ...
(Date:8/21/2014)... The report "Industrial Flue Gas Treatment Systems ... DeNOx, Particulate Control, Mercury Control) by Application (Power ... - Global Trends & Forecasts to 2019" defines ... systems & services market with analysis and projection ... value. The industrial flue gas treatment systems & ...
(Date:8/21/2014)... 21, 2014 Lauren Collura, a mother of ... “Back to the Boardwalk” Facebook sweepstakes. Lauren, her husband, and ... four-bedroom beachfront house in Lavallette beginning this Saturday. , ... Boardwalk” sweepstakes. Last year, Horizon Blue Cross Blue Shield of ... Superstorm Sandy and decided to make it a new summer ...
(Date:8/21/2014)... 2014 American Addiction Centers, a leading ... individuals with drug and/or alcohol addiction, has been named ... Private Companies. , The company is ranked 7th on ... and 4th on the list in the “Nashville Metro ... 995%, American Addiction Centers (AAC) ascended to number 474 ...
Breaking Medicine News(10 mins):Health News:Objectification in romantic relationships related to sexual pressure and coercion 2Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4Health News:American Addiction Centers Named to Inc. 500 List Recognition for Three-Year Sales Growth of 995% 2
... adults in their late 30,s received a flu shot during ... study released today says. But about 65 percent were ... percent said they were following the issue very or moderately ... adults during the 2009-2010 H1N1 influenza epidemic, this second of ...
... Doheny HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay ... the risk of getting ovarian cancer, but new research shows ... surviving the deadly disease. Women with invasive epithelial ovarian ... women without the genetic variations, according to an analysis of ...
... practiced as part of routine care for people with ... pressure and cholesterol levels and keep them under control, ... February issue of Diabetes Care . Researchers ... cohort study of more than 30,000 people with diabetes ...
... , TUESDAY, Jan. 24 (HealthDay News) -- Psychedelic ... suggest two small brain imaging studies that seem to ... mushrooms -- affects the brain. One study included ... blood while magnetic resonance imaging (MRI) scanners measured changes ...
... HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay ... and other signs of gastroesophageal reflux don,t get additional ... And, taking these medications when there are ... a respiratory infection, reports the study. "There,s a ...
... , TUESDAY, Jan. 24 (HealthDay News) -- Obstetricians ... partner violence, including during prenatal visits, according to ... and Gynecologists. In addition, ob-gyns should offer ... on hand to give to patients who are ...
Cached Medicine News:Health News:Young adults responded well to swine flu 2Health News:Gene Mutations May Boost Ovarian Cancer Survival: Study 2Health News:Gene Mutations May Boost Ovarian Cancer Survival: Study 3Health News:Lifestyle counseling reduces time to reach treatment goals for people with diabetes 2Health News:Could 'Magic' Mushrooms Ease Depression? 2Health News:Could 'Magic' Mushrooms Ease Depression? 3Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 2Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 3Health News:Ob-Gyns Should Screen for Domestic Abuse: Experts 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: